Aileron Therapeutics Inc (ALRN)
3.20
-0.01
(-0.31%)
USD |
NASDAQ |
May 31, 16:00
3.21
+0.01
(+0.31%)
After-Hours: 20:00
Aileron Therapeutics Enterprise Value: 57.04M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 57.04M |
| May 30, 2024 | 57.26M |
| May 29, 2024 | 58.99M |
| May 28, 2024 | 61.58M |
| May 24, 2024 | 63.74M |
| May 23, 2024 | 66.98M |
| May 22, 2024 | 67.84M |
| May 21, 2024 | 69.35M |
| May 20, 2024 | 67.62M |
| May 17, 2024 | 69.35M |
| May 16, 2024 | 71.08M |
| May 15, 2024 | 72.16M |
| May 14, 2024 | 72.16M |
| May 13, 2024 | 71.73M |
| May 10, 2024 | 68.72M |
| May 09, 2024 | 65.55M |
| May 08, 2024 | 65.13M |
| May 07, 2024 | 65.97M |
| May 06, 2024 | 71.47M |
| May 03, 2024 | 67.45M |
| May 02, 2024 | 52.40M |
| May 01, 2024 | 58.13M |
| April 30, 2024 | 64.71M |
| April 29, 2024 | 70.95M |
| April 26, 2024 | 72.30M |
| Date | Value |
|---|---|
| April 25, 2024 | 72.30M |
| April 24, 2024 | 71.63M |
| April 23, 2024 | 68.58M |
| April 22, 2024 | 68.58M |
| April 19, 2024 | 68.41M |
| April 18, 2024 | 72.82M |
| April 17, 2024 | 60.09M |
| April 16, 2024 | 78.76M |
| April 15, 2024 | 88.60M |
| April 12, 2024 | 92.17M |
| April 11, 2024 | 84.13M |
| April 10, 2024 | 85.81M |
| April 09, 2024 | 87.16M |
| April 08, 2024 | 92.38M |
| April 05, 2024 | 83.29M |
| April 04, 2024 | 87.33M |
| April 03, 2024 | 86.32M |
| April 02, 2024 | 89.69M |
| April 01, 2024 | 86.66M |
| March 28, 2024 | 15.08M |
| March 27, 2024 | 16.55M |
| March 26, 2024 | 10.53M |
| March 25, 2024 | 11.41M |
| March 22, 2024 | 12.98M |
| March 21, 2024 | 10.39M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-19.67M
Minimum
Aug 02 2022
172.20M
Maximum
Jan 25 2021
14.59M
Average
0.1239M
Median
Jan 11 2022
Enterprise Value Benchmarks
| EyePoint Pharmaceuticals Inc | 258.48M |
| INVO Bioscience Inc | 12.27M |
| Bio-Path Holdings Inc | 3.29M |
| SINTX Technologies Inc | -1.081M |
| Sensus Healthcare Inc | 74.28M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.113M |
| Total Expenses (Quarterly) | 7.205M |
| EPS Diluted (Quarterly) | -0.86 |
| Earnings Yield | -100.6% |